Location:International Convention Centre, Darling Harbour
COSA’s 44th ASM will have a focus on immunotherapy with a subtheme of implementing quality and safety in cancer care. These are hot topics in oncology at the moment, so we are confident we can deliver a program with something for everyone.
New immunotherapy treatments have shown great success in melanoma, and more recently in lung, bladder, kidney and pancreatic cancers to name a few. We plan to feature as many as possible in the ASM program.
The inclusion of quality and safety will complement the strong molecular and therapeutic theme of immunotherapy. In this subtheme we will focus on: the cost and value of cancer care and treatments; the implementation and de-implementation of evidence into practice; preventing errors in cancer care; why quality improvement matters; and discuss tips for choosing wisely.
For more information, see http://www.cosa2017.org/